COVID-19 vaccine development: It’s a relay race
The reason trials are taking shorter time is because developers are taking more risks
As cholera cases rise, demand for vaccines still outpace supply: WHO
Clinical trials with Korean institute-developed oral cholera vaccine showed 65 per cent protection efficacy in India
Monkeypox continues to spread in non-endemic countries, no deaths reported yet
That no patient has travel history to endemic area has experts worried
COVID-19: How is expiration date of vaccines determined?
Expired vaccines are not particularly unsafe or dangerous, say experts
Simply put: Let’s plant a COVID-19 vaccine
Tika Utsav and Vaccine Maitri: Finding the right balance
67% medicines produced in India are exported to developing countries
Hesitancy, logistical challenges behind low turnout at vaccination camps in West Bengal
State is vaccinating health workers beyond the online list generated by Co-WIN app to attain target
India starts COVID-19 vaccination drive; Modi calls doubts over vaccine ‘propaganda’
Prime Minsiter urges people to not drop caution even after being vaccinated
Oxford COVID vaccine authorised in the UK – global health expert on why this is a key moment
To know the impact of the Oxford vaccine, we’ll have to wait and see. However, amid the intense doom and gloom of 2020, having multiple …
WHO launches ‘The Big Catch-Up’ to restore immunisation progress lost during pandemic
More than 100 countries registered a drop in immunisation levels during the COVID-19 pandemic
Roti, kapda, makaan... and vaccine: Can it sway elections
With potential COVID-19 vaccines equalling cheap foodgrains’ power as a poll promise, can vaccine sub-nationalism be far behind
Low vaccine coverage could be behind measles outbreaks: WHO
The world saw 300 per cent more cases in the first three months of 2019 compared to last year
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
Moderna is not committed to ‘vaccine equity’: Africa CDC
Moderna's decision to abandon plans to construct vaccine plants in Kenya drew flak from African Union's public health agency
Three medical innovations fuelled by COVID-19 that will outlast the pandemic
Gene-based vaccines had never been approved for humans before the coronavirus pandemic
WHO welcomes Afghanistan’s decision to resume door-to-door polio vaccination
The campaign will also cover more than 3.3 million children across the country who didn’t have access to the vaccine so far
Countries relying on Chinese COVID-19 vaccines see surge in cases: Report
Chile, Bahrain, Mongolia and the Sychelles relied on Chinese vaccines to inoculate their populations; all have registered a spike in COVID-19 …
COVID-19 vaccines: Did a delayed second dose give the delta variant an evolutionary helping hand?
Those with a single dose of the Pfizer or AstraZeneca vaccine less-protected than those with 2 doses: Public Health England
Resurgence of COVID-19 cases serious concern: Centre
‘Clinical trial mode’ condition of Covaxin manufactured by Bharat Biotech International taken off; Covaxin granted licence similar to …
Vaccine-derived polio virus found 50 times in India in six years
The vaccine-derived polio virus is a rare strain of polio virus that has genetically mutated from the strain contained in the oral polio vaccine
Gujarat recipients gung-ho on COVID-19 vaccine
The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round
COVID-19 immunity: how long does it last?
In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic
A vaccine only for Omicron: Does India really need it?
Experts bat for considering benefits, economics carefully before spending on bivalent shots
Cervical cancer: 90% deaths in low and middle income countries with least access to HPV vaccine, screening
These countries also have low rates of vaccination against HPV
India should not prefer Russian COVID-19 vaccine over own: Vaccinologist Peter Hotez
India has a golden chance to emerge as a superpower; vaccine dissemination would be a paramount challenge, Hotez says in an …